Various aberrant ion-transporting proteins (channels, pumps, and carriers) or the deranged expression of their normal (healthy) variants have been experimentally linked to the process of tumorigenesis (tumor development and progression) [67]. The gene discussed is SLC22A23; the disease is neoplasm.